SE9503495L - Nytt protein - Google Patents
Nytt proteinInfo
- Publication number
- SE9503495L SE9503495L SE9503495A SE9503495A SE9503495L SE 9503495 L SE9503495 L SE 9503495L SE 9503495 A SE9503495 A SE 9503495A SE 9503495 A SE9503495 A SE 9503495A SE 9503495 L SE9503495 L SE 9503495L
- Authority
- SE
- Sweden
- Prior art keywords
- gly
- asp
- protein
- ser
- trp
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 7
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 241000193996 Streptococcus pyogenes Species 0.000 abstract 2
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 abstract 2
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 abstract 1
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 abstract 1
- KGAJCJXBEWLQDZ-UBHSHLNASA-N Asp-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N KGAJCJXBEWLQDZ-UBHSHLNASA-N 0.000 abstract 1
- XDGBFDYXZCMYEX-NUMRIWBASA-N Asp-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)O XDGBFDYXZCMYEX-NUMRIWBASA-N 0.000 abstract 1
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 abstract 1
- YODBPLSWNJMZOJ-BPUTZDHNSA-N Asp-Trp-Arg Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N YODBPLSWNJMZOJ-BPUTZDHNSA-N 0.000 abstract 1
- BOXNGMVEVOGXOJ-UBHSHLNASA-N Asp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N BOXNGMVEVOGXOJ-UBHSHLNASA-N 0.000 abstract 1
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- 102000003780 Clusterin Human genes 0.000 abstract 1
- 108090000197 Clusterin Proteins 0.000 abstract 1
- 102000015833 Cystatin Human genes 0.000 abstract 1
- VHPVBPCCWVDGJL-IRIUXVKKSA-N Glu-Thr-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VHPVBPCCWVDGJL-IRIUXVKKSA-N 0.000 abstract 1
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 abstract 1
- NSVOVKWEKGEOQB-LURJTMIESA-N Gly-Pro-Gly Chemical compound NCC(=O)N1CCC[C@H]1C(=O)NCC(O)=O NSVOVKWEKGEOQB-LURJTMIESA-N 0.000 abstract 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 abstract 1
- ONSARSFSJHTMFJ-STQMWFEESA-N Gly-Trp-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(O)=O ONSARSFSJHTMFJ-STQMWFEESA-N 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 206010018910 Haemolysis Diseases 0.000 abstract 1
- DYKZGTLPSNOFHU-DEQVHRJGSA-N His-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N DYKZGTLPSNOFHU-DEQVHRJGSA-N 0.000 abstract 1
- 108010065920 Insulin Lispro Proteins 0.000 abstract 1
- GQUDMNDPQTXZRV-DCAQKATOSA-N Lys-Arg-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O GQUDMNDPQTXZRV-DCAQKATOSA-N 0.000 abstract 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 abstract 1
- VDVYTKZBMFADQH-AVGNSLFASA-N Ser-Gln-Tyr Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 VDVYTKZBMFADQH-AVGNSLFASA-N 0.000 abstract 1
- 241000194017 Streptococcus Species 0.000 abstract 1
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 abstract 1
- JVTHMUDOKPQBOT-NSHDSACASA-N Trp-Gly-Gly Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O)=CNC2=C1 JVTHMUDOKPQBOT-NSHDSACASA-N 0.000 abstract 1
- IVBJBFSWJDNQFW-XIRDDKMYSA-N Trp-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IVBJBFSWJDNQFW-XIRDDKMYSA-N 0.000 abstract 1
- ARKBYVBCEOWRNR-UBHSHLNASA-N Trp-Ser-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O ARKBYVBCEOWRNR-UBHSHLNASA-N 0.000 abstract 1
- SLCSPPCQWUHPPO-JYJNAYRXSA-N Tyr-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 SLCSPPCQWUHPPO-JYJNAYRXSA-N 0.000 abstract 1
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 108010091092 arginyl-glycyl-proline Proteins 0.000 abstract 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 abstract 1
- 108050004038 cystatin Proteins 0.000 abstract 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 abstract 1
- 108010020688 glycylhistidine Proteins 0.000 abstract 1
- 108010087823 glycyltyrosine Proteins 0.000 abstract 1
- 108010037850 glycylvaline Proteins 0.000 abstract 1
- 230000008588 hemolysis Effects 0.000 abstract 1
- 108010003700 lysyl aspartic acid Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007918 pathogenicity Effects 0.000 abstract 1
- 108010029020 prolylglycine Proteins 0.000 abstract 1
- 239000002510 pyrogen Substances 0.000 abstract 1
- 108010058119 tryptophyl-glycyl-glycine Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9503495A SE9503495L (sv) | 1995-10-09 | 1995-10-09 | Nytt protein |
| AU72332/96A AU7233296A (en) | 1995-10-09 | 1996-10-02 | Streptoccal inhibitor of complement-mediated lysis, protein sic |
| PCT/SE1996/001238 WO1997013786A1 (en) | 1995-10-09 | 1996-10-02 | Streptoccal inhibitor of complement-mediated lysis, protein sic |
| US09/051,380 US6576741B1 (en) | 1995-10-09 | 1996-10-02 | Streptoccal inhibitor of complement-mediated lysis, protein SIC |
| DE69634206T DE69634206D1 (de) | 1995-10-09 | 1996-10-02 | Sic protein von streptococcus, ein inhibitor der komplement-vermittelten lyse |
| EP96933703A EP0862580B1 (en) | 1995-10-09 | 1996-10-02 | Streptoccal inhibitor of complement-mediated lysis, protein sic |
| US10/374,535 US7361750B2 (en) | 1995-10-09 | 2003-02-26 | Streptoccal inhibitor of complement-mediated lysis, protein SIC |
| US11/418,770 US7588762B2 (en) | 1995-10-09 | 2006-05-05 | Streptoccal inhibitor of complement-mediated lysis, protein SIC |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9503495A SE9503495L (sv) | 1995-10-09 | 1995-10-09 | Nytt protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE9503495D0 SE9503495D0 (sv) | 1995-10-09 |
| SE9503495L true SE9503495L (sv) | 1997-04-10 |
Family
ID=20399743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9503495A SE9503495L (sv) | 1995-10-09 | 1995-10-09 | Nytt protein |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US6576741B1 (sv) |
| EP (1) | EP0862580B1 (sv) |
| AU (1) | AU7233296A (sv) |
| DE (1) | DE69634206D1 (sv) |
| SE (1) | SE9503495L (sv) |
| WO (1) | WO1997013786A1 (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003520034A (ja) * | 1999-12-23 | 2003-07-02 | ヴィマックス リミテッド | ビルレンス遺伝子、タンパク質、およびそれらの用途 |
| WO2002072624A2 (en) * | 2001-03-14 | 2002-09-19 | Cambridge University Technical Services Limited | Assays, methods and means for targeting streptococcal inhibitor of complement (sic) |
| FR2886312B1 (fr) * | 2005-05-26 | 2012-12-14 | Abag | Nouvelles proteines permettant la mise en evidence in vitro et la prevention des infections a streptococcus pyogenes |
| WO2008044928A1 (en) | 2006-10-10 | 2008-04-17 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Complement inhibition for improved nerve regeneration |
| CA3248223A1 (en) * | 2022-01-26 | 2023-08-03 | Idexx Laboratories, Inc. | METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0367890A1 (en) | 1988-11-11 | 1990-05-16 | HighTech Receptor AB | Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof |
| JP2871709B2 (ja) * | 1988-11-21 | 1999-03-17 | 住友製薬株式会社 | 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法 |
| SE9002212D0 (sv) | 1990-06-21 | 1990-06-21 | Hightech Receptor Ab | Igg binding protein |
-
1995
- 1995-10-09 SE SE9503495A patent/SE9503495L/sv not_active Application Discontinuation
-
1996
- 1996-10-02 AU AU72332/96A patent/AU7233296A/en not_active Abandoned
- 1996-10-02 DE DE69634206T patent/DE69634206D1/de not_active Expired - Lifetime
- 1996-10-02 WO PCT/SE1996/001238 patent/WO1997013786A1/en not_active Ceased
- 1996-10-02 EP EP96933703A patent/EP0862580B1/en not_active Expired - Lifetime
- 1996-10-02 US US09/051,380 patent/US6576741B1/en not_active Expired - Fee Related
-
2003
- 2003-02-26 US US10/374,535 patent/US7361750B2/en not_active Expired - Fee Related
-
2006
- 2006-05-05 US US11/418,770 patent/US7588762B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6576741B1 (en) | 2003-06-10 |
| WO1997013786A1 (en) | 1997-04-17 |
| US20060205925A1 (en) | 2006-09-14 |
| EP0862580B1 (en) | 2005-01-19 |
| WO1997013786A9 (en) | 2008-09-04 |
| DE69634206D1 (de) | 2005-02-24 |
| SE9503495D0 (sv) | 1995-10-09 |
| US7361750B2 (en) | 2008-04-22 |
| US20040010117A1 (en) | 2004-01-15 |
| US7588762B2 (en) | 2009-09-15 |
| AU7233296A (en) | 1997-04-30 |
| EP0862580A1 (en) | 1998-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Anders et al. | Isolation and characterization of amyloid‐related serum protein SAA as a low molecular weight protein | |
| Carlen et al. | Composition of pellicles formed in vivo on tooth surfaces in different parts of the dentition, and in vitro on hydroxyapatite | |
| Takagi et al. | Amino acid sequence studies on the α chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site | |
| Blombäck et al. | Primary Structure of Human Fibrinogen and Fibrin: II. STRUCTURAL STUDIES ON NH2-TERMINAL PART OF γ CHAIN | |
| Spiegelberg et al. | Structural studies of human γD myeloma protein | |
| MX9202724A (es) | Composicion que comprende un vector recombinante del agente lelystad y vacuna que comprende la misma. | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| BRPI0011369B8 (pt) | método de detecção precoce e kit de diagnóstico precoce de uma infecção flaviviral, processo de purificação da proteína ns1 de um flavivírus,composição imunogênca,utilização da proteína ns1,de pelo menos um anticorpo monoclonal anti-ns1 e da proteína ns1 de forma hexamérica,e, processo de expressão de um polinucleotídeo codificado para a proteína ns1 de um vírus da dengue | |
| NO20025153D0 (no) | FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1 | |
| BR0012919A (pt) | Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv | |
| UY24130A1 (es) | Peptido p277 analogos, y composiciones farmaceuticas que los comprenden para el tratamiento o diagnostico de diabetes. | |
| RU2006134631A (ru) | Иммуногенные композиции против chlamidia pneumoniae | |
| SE9503495D0 (sv) | New protein | |
| Prahl et al. | Carboxy-terminal structure of the α chain of human IgA [immunoglobulin A] myeloma proteins | |
| DE69529272D1 (de) | MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA | |
| REICHERT JR et al. | On the isolation and characterization of the alpha and beta subunits of human pituitary follicle-stimulating hormone | |
| Cates et al. | C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria | |
| CA2259413A1 (en) | Methods for determining the presence of brain protein s-100 | |
| FI913714A0 (fi) | Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter. | |
| NO903681L (no) | Monoklonale antistoffer mot aktiverte ras-proteiner med aminosyremutasjoner i posisjon 13 i proteinet. | |
| Clyne et al. | Characterization of staphylococcal λ-lysin | |
| Kelly et al. | Immunological studies on the major haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum | |
| BR9908476A (pt) | Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae | |
| Carding et al. | Multiple proteins related to the soluble galactose-binding animal lectin revealed by a monoclonal anti-lectin antibody | |
| AU9629498A (en) | Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 9503495-5 |